Sézary syndrome managed with histone deacetylase inhibitor followed by anti-CCR4 monoclonal antibody

T. Numata, T. Nagatani, K. Shirai, T. Maeda, K. Mae, M. Nakasu, M. Saito, T. Usuda, R. Tsuboi, Y. Okubo
  • Clinical and Experimental Dermatology, January 2018, Wiley
  • DOI: 10.1111/ced.13357
The author haven't yet claimed this publicationThe author haven't yet claimed this publication
Read Publication

http://dx.doi.org/10.1111/ced.13357

In partnership with: